Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 5;29(11):2673.
doi: 10.3390/molecules29112673.

Natural Products with Potential Effects on Hemorrhoids: A Review

Affiliations
Review

Natural Products with Potential Effects on Hemorrhoids: A Review

Yicheng Liang et al. Molecules. .

Abstract

Hemorrhoid disease is a common anorectal disorder affecting populations worldwide, with high prevalence, treatment difficulties, and considerable treatment costs. Compared to other treatment options, medical therapy for hemorrhoids offers minimal harm, more dignity to patients, and is more economical. Unfortunately, there are few chemical hemorrhoid medications available clinically, which makes the search for efficacious, cost-effective, and environmentally friendly new medication classes a focal point of research. In this context, searching for available natural products to improve hemorrhoids exhibits tremendous potential. These products are derived from nature, predominantly from plants, with a minor portion coming from animals, fungi, and algae. They have excellent coagulation pathway regulation, anti-inflammatory, antibacterial, and tissue regeneration activities. Therefore, we take the view that they are a class of potential hemorrhoid drugs, prevention products, and medication add-on ingredients. This article first reviews the factors contributing to the development of hemorrhoids, types, primary symptoms, and the mechanisms of natural products for hemorrhoids. Building on this foundation, we screened natural products with potential hemorrhoid improvement activity, including polyphenols and flavonoids, terpenes, polysaccharides, and other types.

Keywords: hemorrhoid improvement; hemorrhoids; natural products; pharmacological mechanisms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Current status of hemorrhoids.
Figure 2
Figure 2
The complex pharmacological mechanisms of natural products, including anti-inflammatory, hemostatic, and antibacterial properties, and promoting tissue regeneration.
Figure 3
Figure 3
Chemical structures of polyphenols and flavonoids in the table. (1) Curcumin (CAS:458-37-7); (2) emodin (CAS:518-82-1); (3) epigallocatechin gallate (CAS:989-51-5); (4) resveratrol (CAS:501-36-0); (5) genistein (CAS:446-72-0); (6) apigenin (CAS:520-36-5); (7) quercetin (CAS:117-39-5); (8) daidzein (CAS:486-66-8); (9) luteolin (CAS:491-70-3); (10) chrysin (CAS:480-40-0); (11) caffeic acid (CAS:331-39-5); (12) baicalin (CAS:21967-41-9); (13) rutin (CAS:153-18-4); (14) isoquercitrin (CAS:21637-25-2); (15) tannic acid (CAS:1401-55-4).
Figure 4
Figure 4
Chemical structures of terpenoids in the table. (1) Paeoniflorin (CAS:23180-57-6); (2) ginsenoside CK (CAS:39262-14-1); (3) ginsenoside RD (CAS:52705-93-8); (4) compound glycyrrhizin (CAS:1405-86-3); (5) astragaloside IV (CAS:84687-43-4); (6) gentiopicroside (CAS:20831-76-9); (7) Asiatic acid (CAS:464-92-6); (8) stevioside (CAS:57817-89-7); (9) sodium aescinate (CAS:20977-05-3); (10) ginkgolide A (CAS:15291-75-5); (11) ginkgolide B (CAS:15291-77-7); (12) andrographolide (CAS:5508-58-7); (13) menthol (CAS:89-78-1) (Total saponins of achyranthes bidens and soapnut saponin are a mixture, so there is no structural formula).
Figure 5
Figure 5
Chemical structures of other types in the table. (1) Chlorogenic acid (CAS:327-97-9); (2) tetrandrine (CAS:518-34-3); (3) tanshinone IIA (CAS:568-72-9); (4) allicin (CAS:539-86-6); (5) psoralen (CAS:66-97-7); (6) esculin (CAS:531-75-9); (7) esculetin (CAS:305-01-1); (8) berberine (CAS:2086-83-1); (9) matrine (CAS:519-02-8); (10) galectin-1 (CID:169450756) (has no CAS number).

Similar articles

Cited by

References

    1. Yamana T. Japanese Practice Guidelines for Anal Disorders II. Anal fistula. J. Anus Rectum Colon. 2018;2:103–109. doi: 10.23922/jarc.2018-009. - DOI - PMC - PubMed
    1. Jiang W., Zhang H.-X., Sui N. Common anorectal diseases among urban residents in China. Chin. J. Public. Health. 2016;32:1293–1296.
    1. Yang J.Y., Peery A.F., Lund J.L., Pate V., Sandler R.S. Burden and Cost of Outpatient Hemorrhoids in the United States Employer-Insured Population, 2014. Am. J. Gastroenterol. 2019;114:798–803. doi: 10.14309/ajg.0000000000000143. - DOI - PMC - PubMed
    1. Yamana T. Japanese Practice Guidelines for Anal Disorders I. Hemorrhoids. J. Anus Rectum Colon. 2017;1:89–99. doi: 10.23922/jarc.2017-018. - DOI - PMC - PubMed
    1. Lohsiriwat V. Hemorrhoids: From basic pathophysiology to clinical management. World J. Gastroenterol. 2012;18:2009–2017. doi: 10.3748/wjg.v18.i17.2009. - DOI - PMC - PubMed

MeSH terms